Rounds / Metagen Therapeutics
MT
Metagen Therapeutics raises ¥3.5B (Series B)
- Company
- Metagen Therapeutics
- Reported
- 26 Feb 2026 · that week's brief
- Stage
- Series B · 「シリーズB」 · B
- Amount
- ¥3.5B1 · as announced: 「約35億円」
- Breakdown
- Equity ¥3.5B
- Status
- In scopeNot yet registry-confirmed
- Investors
- Canon Marketing Japan MIRAI FundMatsukiyoCocokara & CompanyMedipal Holdings · list incomplete (release ends with 等/ほか)
- Sector
- BiotechDeep tech
- Source
- Primary release (PR TIMES) · BRIDGE coverage
1 ≈ ~$22.43M at the ECB reference rate on 2026-02-26 (¥1 = $0.00641). Yen is the figure of record. Methodology
Get the weekly brief
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →